Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1989 Nov;80(11):1041–1046. doi: 10.1111/j.1349-7006.1989.tb02256.x

Strain Differences in Susceptibility to 2‐Acetylaminofluorene and Phenobarbital Promotion of Hepatocarcinogenesis: Immunohistocliemical Analysis of Cytochrome P‐450 Isozyme Induction by 2‐Acetylaminofluorene and Phenobarbital

Makoto Asamoto 1, Hiroyuki Tsuda 1,†, Toshio Kato 1, Nobuyuki Ito 1, Takashi Masuko 2, Yoshiyuki Hashimoto 2, Sumi Nagase 3
PMCID: PMC5917902  PMID: 2514165

Abstract

Strain differences in the expression of cytochrome P‐450 isoenzymes (P‐450s) during enhancement of hepatocarcinogenesis by 2‐acetylaminofluorene (2‐AAF) and phenobarbital (PB) were investigated immunohistochemically using monoclonal antibodies against phenobarbital (PB) (APF3) or 3‐methylcholanthrene (3‐MC) (APH8) inducible P‐450s. LEW, SD, WBN, F344, SHR, NAR, Wistar and ODS rats were studied, the first five strains proving to be less susceptible to 2‐AAF induction of APH8 while responding strongly to the promoting influence of this chemical, as reported previously. The other three strains, NAR, Wistar and ODS, demonstrated greater inducibility, this correlating with an observed resistance to promotion by 2‐AAF. PB administration was not associated with any strain difference in APF3 cytochrome P‐4SO inducibility except in the ODS rat, in which its effects were minimal. The results provide direct evidence that differential expression of cytochrome P‐450 species plays a major role in determining responsiveness to hepatocarcinogenesis‐promoting agents such as 2‐AAF.

Keywords: Strain differences, Rat hepatocarcinogenesis, Cytochrome P‐450, Immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (696.9 KB).

REFERENCES

  • 1. ) Asamoto , M. , Tsuda , H. , Kagawa , M. , de Camargo , J. L. , V. , Ito , N. and Nagase , S.Strain differences in susceptibility to 2‐acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium‐term assay system: quantitation of glutathione S‐transferase P‐positive foci development . Jpn. J, Cancer Res. , 80 , 939 – 944 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. ) Cameron , R. , Sharma , R. N. , Sweeney , G. D. , Farber , E. and Murray , R. K.A novel electrophoretic pattern of induction of rat liver microsomal membrane polypeptides by 2‐acetylaminofluorene, nitrosamjne and azo dye administration . Biochem. Biophys. Res. Commun. , 71 , 1054 – 1061 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Sato , M. , Yoshida , T. , Suzuki , Y. , Degawa , M. and Hashimoto , Y.Selective induction of microsomal 2‐acetylaminofluorene N‐hydroxylation by dietary 2‐acetylaminofluorene in rats . Carcinogenesis , 2 , 571 – 574 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Hino , O. , Nemoto , N. , Nagao , M. , Kosugi , A , and Kitagawa , T.Induction of drug‐metabolizing enzymes in rat liver by 3′‐mehtyl‐4‐(dimethylamino)azobenzene . Cancer Lett. , 15 , 131 – 136 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Ryan , D. E. , Thomas , P. E. , Karzenowski , D. and Levin , W.Separation and characterization of highly purified forms of liver microsomal cytochrome P‐450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3‐methylcholanthrene . J. Biol. Chem. , 256 , 1044 – 1052 ( 1979. ). [PubMed] [Google Scholar]
  • 6. ) Ryan , D. E. , Thomas , P. E. and Levin , W.Hepatic microsomal cytochrome P‐450 from rats treated with isosafrole: purification and characterization of four en‐zymic forms . J. Biol. Chem. , 255 , 7941 – 7955 ( 1980. ). [PubMed] [Google Scholar]
  • 7. ) Hashimoto , Y. , Masuko , T. , Itoh , K. , Yagita , H. , Hishinuma , T. , Degawa , M. , Kamataki , T. and Koto , R.Monoclonal antibodies against a high spin form of rat cytochrome P‐448 . Biochem. Biophys. Res. Commun. , 131 , 600 – 606 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Masuko , T. , Sugahara , K. , Nakajima , S. and Hashimoto , Y.Altered expression of immunohistochemically detected cytochrome P‐450 component(s) in nitrosamine‐induced rat urinary bladder lesion . Jpn. J. Cancer Res. , 78 , 840 – 845 ( 1987. ). [PubMed] [Google Scholar]
  • 9. ) Hsu , S. M. , Raine , Y. and Fanger , H.Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures . J. Histochem. Cytochem. , 29 , 577 – 580 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Cameron , R. , Sweeney , G. D. , Jones , K. , Lee , G. and Farber , E.A relative deficiency of cytochrome P‐450 and aryl hydrocarbon (benzo [a] pyrene) hydroxylase in hyper‐plastic nodules induced by 2‐acetylaminofluorene in rat liver . Cancer Res. , 36 , 3888 – 3893 ( 1976. ). [PubMed] [Google Scholar]
  • 11. ) Okita , K. , Noda , K. , Fukumoto , Y. and Takemoto , T.Cytochrome P‐450 in hyperplastic liver nodules during hepatocarcinogenesis with N‐2‐fluorenylacetamide in rats . Gann , 67 , 899 – 902 ( 1976. ). [PubMed] [Google Scholar]
  • 12. ) Astrom , A. , De Piere , J. W. and Eriksson , L.Characterization of drug metabolizing systems in hyperplastic nodules from the livers of rats receiving 2‐acetylaminofluorene in their diet . Carcinogenesis , 4 , 577 – 581 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Buchmann , A. , Kuhlmann , W. , Schwarze , M. , Kunz , W. , Wolf , C. R. , Moll , E. , Friedberg , T. and Oesch , F.Regulation and expression of four cytochrome P‐450 isoenzymes, NADPH‐cytochrome P‐450 reductase, the glutathione transferase B and C and Microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver . Carcinogenesis , 6 , 513 – 521 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Tsuda , H. , Moore , M. A. , Asamoto , M. , Inoue , T. , Fukushima , S. , Ito , N. , Satoh , K. , Amelizad , Z. and Oesch , F.Immunohistochemically demonstrated altered expression of cytochrome P‐450 molecular forms and epoxide hydrolase in N‐ethyl‐N‐hydroxyethylnitrosamine‐induced rat kidney and liver lesions . Carcinogenesis , 8 , 711 – 717 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Farber , E.Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes memorial lecture . Cancer Res. , 44 , 5463 – 5474 ( 1984. ). [PubMed] [Google Scholar]
  • 16. ) Schulte‐Hermann , R. , Roome , N. , Timmermann‐Trosiener , I. and Schuppler , J.Immunocytochemical demonstration of a phenobarbital‐inducible cytochrome P450 in putative preneoplastic foci of rat liver . Carcinogenesis , 5 , 149 – 153 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Schwarz , M. , Peres , G. , Buchmann , A. , Friedberg , T. , Waxman , D. J. and Kunz , W.Phenobarbital induction of cytochrome P‐450 in normal and preneoplastic rat liver: comparison of enzyme and mRNA expression as detected by immunohistochemistry and in situ hybridization . Carcinogenesis , 8 , 1355 – 1357 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Makino , S. and Katagiri , K.Osteogenic disorder rat . Exp. Anim. , 29 , 374 – 375 ( 1980. ) ( in Japanese ). [Google Scholar]
  • 19. ) Horio , F. , Ozaki , K. , Yoshida , A. , Makino , S. and Hayashi , Y.Requirement for ascorbic acid in rat mutants unable to synthesize ascorbic acid . J. Nutr. , 115 , 1630 – 1640 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Horio , F. , Ozaki , K. , Kohmura , M. , Yoshida , A. , Makino , S. and Hayashi , Y.Ascorbic acid requirement for the induction of microsomal drug‐metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid . J. Nutr. , 116 , 2278 – 2289 ( 1986. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES